| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aldosterone
|
Sbolli, Marco
|
|
|
8 |
12 |
p. 1021-1023
|
artikel
|
| 2 |
Associations Between Depressive Symptoms and HFpEF-Related Outcomes
|
Chandra, Alvin
|
|
|
8 |
12 |
p. 1009-1020
|
artikel
|
| 3 |
Calorie Intake, Post-Discharge Outcomes in Heart Failure, and Food Insecurity
|
Mehmood, Muddassir
|
|
|
8 |
12 |
p. 1052
|
artikel
|
| 4 |
Cause of Death in Patients With Acute Heart Failure
|
Loungani, Rahul S.
|
|
|
8 |
12 |
p. 999-1008
|
artikel
|
| 5 |
Changing U.S. Heart Failure Research Culture: Part 2—Recognizing Frontline Investigators and Coordinators
|
O’Connor, Christopher M.
|
|
|
8 |
12 |
p. 1050-1051
|
artikel
|
| 6 |
Correction
|
|
|
|
8 |
12 |
p. 1059
|
artikel
|
| 7 |
Correction
|
|
|
|
8 |
12 |
p. 1058-1059
|
artikel
|
| 8 |
Correction
|
|
|
|
8 |
12 |
p. 1057
|
artikel
|
| 9 |
Estimating the Lifetime Benefits of Treatments for Heart Failure
|
Ferreira, João Pedro
|
|
|
8 |
12 |
p. 984-995
|
artikel
|
| 10 |
From Reactivity to Proactivity
|
Desai, Nihar R.
|
|
|
8 |
12 |
p. 1035-1037
|
artikel
|
| 11 |
Health Care Use Before First Heart Failure Hospitalization
|
Anderson, Kim
|
|
|
8 |
12 |
p. 1024-1034
|
artikel
|
| 12 |
Home Health Care Use and Post-Discharge Outcomes After Heart Failure Hospitalizations
|
Sterling, Madeline R.
|
|
|
8 |
12 |
p. 1038-1049
|
artikel
|
| 13 |
Insights From HeartLogic Multisensor Monitoring During the COVID-19 Pandemic in New York City
|
Mitter, Sumeet S.
|
|
|
8 |
12 |
p. 1053-1055
|
artikel
|
| 14 |
Patient-Centered Measures of Treatment Benefit ∗
|
Leifer, Eric S.
|
|
|
8 |
12 |
p. 996-998
|
artikel
|
| 15 |
Reply
|
Hummel, Scott L.
|
|
|
8 |
12 |
p. 1052-1053
|
artikel
|
| 16 |
Reply
|
DeFilippis, Ersilia M.
|
|
|
8 |
12 |
p. 1055-1056
|
artikel
|
| 17 |
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium
|
Abraham, William T.
|
|
|
8 |
12 |
p. 961-972
|
artikel
|
| 18 |
Utility of Restricted Mean Survival Time Analysis for Heart Failure Clinical Trial Evaluation and Interpretation
|
Perego, Carlotta
|
|
|
8 |
12 |
p. 973-983
|
artikel
|
| 19 |
When and for Whom Should We Use SGLT2 Inhibitors in HFrEF?
|
Tanaka, Atsushi
|
|
|
8 |
12 |
p. 1056
|
artikel
|
Tijdschrift beschrijving